Log in or Sign up for Free to view tailored content for your specialty!
Wound Management News
FDA approves TPOXX to treat smallpox
The FDA has approved an oral formulation of TPOXX for the treatment of smallpox, citing concerns that the infectious disease, long considered eradicated since 1980, could potentially be used as a bioweapon, according to a press release.
Fourth of July: How to protect kids from firework-related injuries
Fireworks are a ubiquitous presence among Fourth of July celebrations; however, these bright and colorful displays pose a danger to children who may want to handle these dangerous products.
Log in or Sign up for Free to view tailored content for your specialty!
US military explores microbiology of combat wounds
ATLANTA — To help improve the care of troops injured in combat, the United States military has been exploring the complex microbiology of combat wounds.
MSSA hospital costs may soon exceed those of MRSA
Methicillin-susceptible Staphylococcus aureus has begun to incur similar hospitalization costs and may ultimately exceed those of MRSA, researchers reported in Clinical Infectious Diseases.
Iclaprim safe, potentially cost-effective for ABSSSIs
Motif Bio announced additional safety data from its REVIVE-2 trial of the investigational antibiotic iclaprim, showing that the treatment was well-tolerated in patients with acute bacterial skin and skin structure infections, or ABSSSIs. Other findings, presented at the European Congress of Clinical Microbiology and Infectious Diseases, showed that the drug could reduce the cost burden of acute kidney injury normally associated with vancomycin, which is currently the standard of care.
Paratek Pharmaceuticals releases omadacycline topline results
Omadacycline is effective in treating acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia, according to topline results presented at the European Congress of Clinical Microbiology and Infectious Diseases.
Patients with Buruli ulcer benefit by delaying surgery decision
Study findings suggest that patients being treated for Buruli ulcer benefit from delaying the decision of whether to undergo excision surgery, once the main treatment option for the often debilitating neglected tropical disease, researchers said.
Short-course AmBisome effective against persistent leishmaniasis
A 15-mg/kg dose of AmBisome given over 15 days in five biweekly infusions was safe and effective against post-kala-azar dermal leishmaniasis, or PKDL, a condition in which Leishmania parasites persist despite successful visceral leishmaniasis treatment, according to researchers.
Ceramide-infused skin barrier reduces costs, complications in ostomy care
Using an ostomy skin barrier infused with ceramide resulted in lower costs and improved satisfaction for patients, according to a study published in the Journal of Wound, Continence and Ostomy Nursing.
GI, respiratory, skin disease top list among troops in Ebola response
SAN DIEGO — Complaints of upper respiratory, gastrointestinal and skin disease symptoms accounted for the majority of clinical visits by United States military personnel during their response to the 2014 Ebola virus outbreak in West Africa, according to researchers.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read